Physician profile
Michael Miller
NPI 1326627001
$1,313.42
in general payments reported to CMS, 2019-2025
9 companies · $848 in 2025
The $848 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $465 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $452.53 | 2024-2025 | Wegovy |
| Medtronic, INC. | $396.29 | 2024-2025 | Azure Xt Dr Mri Surescan, Claria Mri Quad Crt-D Surescan, Omniasecure Mri Surescan |
| Amgen INC. | $139.09 | 2024-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $71.58 | 2024-2025 | Camzyos |
| Pfizer INC. | $69.48 | 2025 | |
| Abbott Laboratories | $68.42 | 2025 | Cardiomems, Triclip |
| Boston Scientific Corporation | $62.45 | 2024-2025 | Emblem Mri S-Icd |
| Alnylam Pharmaceuticals INC. | $34.44 | 2025 | Onpattro |
| Merck Sharp & Dohme LLC | $19.14 | 2025 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.